Systemic corticosteroids in chronic obstructive pulmonary disease exacerbations (SCCOPE): Rationale and design of an equivalence trial

Controlled Clinical Trials

Volumn 19, Issue 4, 1998, Pages 404-417

  Erbland, Marcia L ^a   Deupree, Robert H ^b   Niewoehner, Dennis E ^c  

^a CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Chronic obstructive pulmonary disease; Corticosteroids; Equivalence trial

Indexed keywords

CORTICOSTEROID; METHYLPREDNISOLONE;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BIOEQUIVALENCE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DESIGN; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; GASTROINTESTINAL HEMORRHAGE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; SUPERINFECTION; TREATMENT FAILURE;

DOUBLE-BLIND METHOD; FORCED EXPIRATORY VOLUME; GLUCOCORTICOIDS; HUMANS; LUNG DISEASES, OBSTRUCTIVE; METHYLPREDNISOLONE; PREDNISONE; TREATMENT FAILURE; UNITED STATES;

EID: 0032145869     PISSN: 01972456     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-2456(98)00011-7     Document Type: Article

References (24)

1. Albert R.K., Martin T.R., Lewis S.W. Controlled clinical trial of methylprednisolone in patients with chronic bronchitis and acute respiratory insufficiency. Ann Intern Med. 92:1980;753-758.
2. Emerman C.L., Connors A.F., Lukens T.W.et al. A randomized controlled trial of methylprednisolone in the emergency treatment of acute exacerbations of COPD. Chest. 95:1989;563-567.
3. Rostom A., Mink S., Hebert P.C.et al. The longterm efficacy of methylprednisolone in the treatment of acute exacerbations of COPD. Chest. 106(suppl, 161S [abstract]):1994.
4. Thompson W.H., Nielson C.P., Carvalho P.et al. Controlled trial of oral prednisone in outpatients with acute COPD exacerbation. Am J Respir Crit Care Med. 154:1996;407-412.
5. Callahan C.M., Dittus R.S., Katz B.P. Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease. a meta-analysis Ann Intern Med. 114:1991;216-223.
6. Smyllie H.C., Connolly C.K. Incidence of serious complications of corticosteroid therapy in respiratory disease. Thorax. 23:1968;571-581.
7. Dujovne C.A., Azarnoff D.L. Clinical complications of corticosteroid therapy. a selected review Med Clin North Am. 57:1973;1331-1342.
8. Pagano G., Bruno A., Cavallo-Perin L.et al. Glucose intolerance after short-term administration of corticosteroids in healthy subjects. prednisone, deflazacort, and betamethasone Arch Intern Med. 149:1989;1098-2001.
9. Van Balkom R.H.H., van der Heijden H.F.M., van Herwaarden C.L.A.et al. Corticosteroid-induced myopathy of the respiratory muscles. Neth J Med. 45:1994;114-122.
10. Lukert B.P., Raisz L.G. Glucocorticoid-induced osteoporosis. pathogenesis and management Ann Intern Med. 112:1990;352-364.
11. American Thoracic Society Standardization of spirometry. 1987 update Am Rev Respir Dis. 136:1987;1285-1298.
12. Mahler D.A., Weinberg D.H., Wells C.K.et al. The measurement of dyspnea. contents, interobserver agreement, and physiologic correlates of two new clinical indexes Chest. 85:1984;751-758.
13. Mahler D.A., Wells C.K. Evaluation of clinical methods for rating dyspnea. Chest. 93:1988;580-586.
14. Blackwelder W.C. "Proving the null hypothesis" in clinical trials. Controlled Clin Trials. 3:1982;345-353.
15. Makuch R., Simon R. Sample size requirements for evaluating a conservative therapy. Cancer Treat Rep. 62:1978;1037-1040.
16. Lan K.K.G., DeMets D.L. Discrete sequential boundaries for clinical trials. Biometrika. 70:1983;659-663.
17. Durrleman S., Simon R. Planning and monitoring of equivalence studies. Biometrics. 46:1990;329-336.
18. Burrows B., Earle R.H. Course and prognosis of chronic obstructive lung disease. a prospective study of 200 patients N Engl J Med. 280:1969;397-404.
19. McGavin C.R., Artivinli M., Naoe H.et al. Dyspnoea, disability, and distance walked. comparison of estimates of exercise performance in respiratory disease Br Med J. 2:1978;241-243.
20. Adinoff A.D., Hollister J.R. Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med. 309:1983;265-268.
21. American Thoracic Society Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis. 136:1987;225-244.
22. Fanta C.H., Rossing T.H., McFadden E.R. Glucocorticoids in acute asthma. a critical controlled trial Am J Med. 74:1983;845-851.
23. Littenberg B., Gluck E.H. A controlled trial of methylprednisolone in the emergency treatment of acute asthma. N Engl J Med. 314:1986;150-152.
24. Pauwels R.A., Löfdahl C.G., Pride N.B.et al. European Respiratory Society study on chronic obstructive pulmonary disease (EUROSCOP). hypothesis and design Eur Respir J. 5:1992;1254-1261.